Insider Trading History of Ward Keith Wayne


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Ward Keith Wayne since year 2005. The trader's CIK number is 1662394. At the time of the last reporting, Ward Keith Wayne was the Chief Development Officer of Reata Pharmaceuticals Inc . (stock ticker symbol RETA). See this page for all insider trading activities at Reata Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Ward Keith Wayne since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-02-26 RETA Reata Pharmaceuticals Inc Sale 25,184 91.31 2,299,551
2019-02-25 RETA Reata Pharmaceuticals Inc Sale 15,183 91.00 1,381,653
2019-01-31 RETA Reata Pharmaceuticals Inc Sale 4,150 76.57 317,765
2019-01-02 RETA Reata Pharmaceuticals Inc Sale 4,150 54.15 224,701
2018-11-07 RETA Reata Pharmaceuticals Inc Sale 4,750 67.39 320,078
2018-11-01 RETA Reata Pharmaceuticals Inc Sale 4,750 59.48 282,530
2018-10-23 RETA Reata Pharmaceuticals Inc Sale 14,250 57.08 813,390
2018-07-05 RETA Reata Pharmaceuticals Inc Sale 4,750 36.62 173,945
2018-06-05 RETA Reata Pharmaceuticals Inc Sale 28,500 36.62 1,043,669

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ward Keith Wayne (Chief Development Officer of Reata Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.